Vancouver, Canada – CDRD, Canada’s national life sciences venture, is pleased to announce an increased commitment to Sitka Biopharma with
CDRD Invests in Sitka Biopharma to Advance Bladder Cancer Treatment to Clinical Trial

by Sitkastaff
Vancouver, Canada – CDRD, Canada’s national life sciences venture, is pleased to announce an increased commitment to Sitka Biopharma with
by Sitkastaff
Vancouver, Canada: Sitka Biopharma is pleased to announce that Quark Venture Inc. and GF Securities, through their Global Health Sciences
by sitkaadmin
Sitka Biopharma Inc. is pleased to announce that Dr. Kristine Swiderek and Dr. Jack Geltosky have joined its Board of
by Sitkastaff
Quark Venture’s early investment in Sitka Biopharma helps the Vancouver-based company advance to clinical trials. We are pleased to announce
by Sitkastaff
June 26, 2017 – Vancouver, BC and London, UK: An experimental treatment for bladder cancer will move into an early
by Sitkastaff
On March 3, 2017 Rocket Builders announced its 15th annual “Ready to Rocket” lists. These lists profile British Columbia technology
by Sitkastaff
Vancouver, Canada – April 13, 2016: Sitka Biopharma is pleased to announce that Quark Venture has made a significant seed
by Sitkastaff
Learn more about Sitka Biopharma’s unique approach to bladder cancer in International Innovation! Drs Helen Burt, Michael Parr, Richard Liggins and
by sitkaadmin
Vancouver, Canada – December 3, 2013: CDRD Ventures Inc. (CVI), the commercialization vehicle of The Centre for Drug Research and